Why the study?
Enhanced cholinergic signaling is linked to cardioprotection, with cardiomyocyte Gi activation via M2 muscarinic receptors proposed as a mechanism, but its therapeutic potential remained to be tested.
Does cardiomyocyte-specific Gi activation prevent or repair adrenergic-induced cardiomyopathy in mice?
Does cardiomyocyte-specific Gi activation prevent or repair adrenergic-induced cardiomyopathy in mice?
Cardiomyocyte-specific Gi activation promotes myocardial repair and preserves function under sustained adrenergic stress in a mouse model, highlighting a potential cell-targeted therapeutic strategy.
Answers are grounded in this paper and cite their sources.
Gi activation in cardiomyocytes may confer protection in mouse adrenergic cardiomyopathy; leaves open clinical translation of this strategy.
Enhanced cholinergic signaling is associated with cardioprotection, with cardiomyocyte Gi activation via M2 muscarinic receptors proposed as a contributing mechanism. To test this therapeutic strategy, we engineered Myh6-Cre/hM4Di mice to selectively activate Gi signaling in cardiomyocytes (CM-Gi + ) using DREADD technology. Gi pathway engagement was temporally controlled through clozapine-N-oxide (CNO) administration, and we evaluated its impact in a model of adrenergic-induced cardiomyopathy. In vitro, CNO reduced myocyte shortening in Myh6-Cre/hM4Di cardiomyocytes. It also suppressed isoproterenol (ISO)-induced contractility enhancement and phosphorylation of PKA target motifs, consistent with Gi activation. In vivo, a 7-day ISO regimen induced cardiac hypertrophy, inflammation, and expression of fibrosis markers, all prevented by CNO-driven CM-Gi + signaling. This intervention also preserved cardiomyocyte viability under ISO challenge in vitro and in vivo, underscoring its cytoprotective effects. To evaluate the therapeutic potential of this cell-targeted approach at a more advanced stage of injury, CNO treatment was initiated on day 4 of a 7-day ISO protocol, when cell death and inflammation are prominent. Echocardiographic, histological and flow cytometry analyses demonstrated that delayed CM-Gi + stimulation restored cardiac function and prevented macrophage accumulation. Contractility assessments confirmed normalization of myocyte function in ISO-treated mice, supporting the concept of cardiomyocyte recovery. Mechanistically, these beneficial effects were associated with reduced cardiac infiltration of CCR2 + monocytes, key drivers of adverse remodeling. Our findings identify cardiomyocyte-specific Gi activation as a cytoprotective strategy that promotes myocardial repair under sustained adrenergic stress. This work lays the foundation for precision cell-targeted therapies aimed at modulating cholinergic/Gi signaling in the injured heart.
No takes yet. Share an insight, caveat, or question.
Eliezeck et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: